APhA encourages pharmacists to provide pharmaceutical care for women, including education about the availability and benefits of opt-out Human Immunodeficiency Virus (HIV) testing in prenatal and perinatal care, to decrease the risk of HIV transmission to unborn children and between partners. APhA encourages pharmacists to provide education about the availability and benefits of opt-out HIV testing in prenatal and perinatal care, including offering and/or performing testing to the patients and their partners.